• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA warns Philips Healthcare on manufacturing plant violations

FDA warns Philips Healthcare on manufacturing plant violations

October 21, 2009 By MassDevice staff

The Food & Drug Administration sent a warning letter to Philips Healthcare warning it of violations found during spot inspections of facilities including a plant in Andover, Mass.

The letter, sent to Philips Healthcare CEO Steve Rusckowski Oct. 9 and posted on the FDA’s website Oct. 20, said spot inspections between January and March this year found that patient monitoring cardiac care products and ultrasound transducers made at the Andover facility and elsewhere were “adulterated,” at least according to federal manufacturing standards.

That means the plants lacked adequate procedures for dealing with complaints within 90 days; according to the letter, several complaints filed in August 2007 concerning automated external defibrillators were not dealt with until January of this year.

The letter, signed by the FDA’s New England district director John Marzilli, said Philips’ response “appears to be adequate” but that further inspections are required to fully settle the issue.

Philips spokesman Steve Kelly told MassDevice in an email that the issues raised in the letter are not related to Philips’ voluntary recall of about 5,400 of its HeartStart FR2+ automated external defibrillators.

Noting that the FDA letter indicated that Philips adequately addressed all of the violations listed in the letter, Kelly wrote that the company will send a response to the agency.

“Philips has been cooperative and responsive to all of FDA’s requests, from the beginning of the inspection onward, providing detailed responses and offering documents to the FDA during and after the inspection,” he wrote. “Philips executives have also offered to meet with the FDA to resolve any remaining questions the agency may have.”

Filed Under: Business/Financial News Tagged With: Cardiac Rhythm Management

More recent news

  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire
  • Medtronic wins CE mark for LigaSure sealing tech for Hugo surgical robot

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy